StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) Pushes Higher after Ending Allergan Deal; Shares Cross Above 200 DMA
April 6, 2016 12:35 PM
Pfizer (NYSE: PFE) is adding to early gains ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Technicals
Trader Talk
Next Articles
Pfizer (PFE) Receives EMA CHMP Approval for MDV Presentation of Prevenar 13
April 6, 2016 11:08 AM
Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®
April 6, 2016 11:00 AM
BMO Capital Reiterates Outperform on Pfizer (PFE) Following Allergan Merger Termination
April 6, 2016 10:42 AM
Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change
April 6, 2016 6:53 AM
Allergan (AGN) Affirms Termination of Pfizer (PFE) Merger; Affirms Strength as Standalone Company
April 6, 2016 6:47 AM
Pfizer (PFE) Announces Termination of Merger Agreement with Allergan (AGN)
April 6, 2016 6:45 AM
